Adelaide Eye & Retina Centre are proud to be involved with a number of clinical trials. We are excited to be involved in the development of new treatments for retinal disease. Our current trials are:
ONS-5010-001 and ONS-5010-002 Study
A clinical effectiveness, multicenter, randomized, double-masked, active controlled study of the efficacy and safety of ONS-5010 in subjects with sub foveal Choroidal Neovascularization (CNV) secondary to age-related macular degeneration (AMD).
A multicenter, double-masked, randomized, dose-ranging trial to evaluate the efficacy and safety of Conbercept intravitreal injection in subjects with Neovascular Age-related Macular Degeneration (AMD).
A two-year, three arm, randomized, double-masked, multicenter, Phase 3 study assessing the efficacy and safety of Brolucizumab versus Aflibercept in adult patients with visual impairment due to Diabetic Macular Edema (DME).
OAKS (APL2-304) Study
A Phase 3, multicenter, randomized, double-masked, sham-controlled study to compare the efficacy and safety of intravitreal APL-2 therapy with sham injections in patients with geographic atrophy (GA) secondary to age-related macular degeneration (AMD).
For urgent referrals:
(08) 8212 3302
Please email us for less urgent contact:
Adelaide Eye and Retina Centre
18 North Terrace, Adelaide.
We are located on the second floor.
18 North Terrace, Adelaide
Marion Eye and Retina Centre
530 Marion Road, Plympton Park.